معرفی
Michael McArthur is a Professor of Nanomedicine at the Norwich Medical School, University of East Anglia. He is a member of the Metabolic Health and Gastroenterology and Gut Biology research groups, based in the Bob Champion Research & Education Building. His research focuses on the development of nanotherapeutics for treating bacterial infections and antimicrobial resistance.
Research Interests: His work spans nanomedicine, antimicrobial drug delivery, microbiome modulation, and biofilm inhibition. He specializes in using nanostructured lipid carriers and bolaamphiphile-based compounds to deliver oligonucleotide therapeutics against resistant pathogens such as MRSA and Burkholderia species.
Recent Research Trends: His recent publications (2019–2024) highlight a consistent focus on nanoparticle-mediated delivery of antimicrobials, multi-omic analysis of drug mechanisms, and modulation of gut microbiota to improve metabolic health. These works reflect interdisciplinary innovation at the intersection of pharmaceutical sciences, microbiology, and metabolic disease.
Scientific Awards:
- BBSRC Most Promising Innovator (2011)
Grants and Projects: He has led or co-led multiple externally funded projects, including:
- Development of a penetrant delivery system for oligonucleotide-based antimicrobials (Defence Science and Technology Laboratory, 2018–2021)
- Nanotherapeutics to treat bacterial infectious diseases (NAREB, EC Framework 7, 2015–2018)
- DNA-TRAP: Delivery of nucleic acid-based therapeutics (EC Framework 7, 2013–2017)
Labs and Teams: He is affiliated with the Norwich Medical School research ecosystem, contributing to the Metabolic Health and Gastroenterology and Gut Biology teams. His lab is involved in developing novel nanocarriers for clinical applications in infectious and metabolic diseases.
